Simplex Trading, LLC Bellus Health Inc. Transaction History

Simplex Trading, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 04, 2023	BUY	$0.0 - $14.75 $0 - $81,788	5,545 Added 89.77%	11,722 $0
Q1 2023 Apr 27, 2023	BUY	$7.14 - $8.53 $44,103 - $52,689	6,177 New	6,177 $44,000
Q3 2022 Nov 04, 2022	BUY	$8.95 - $12.0 $107,704 - $144,408	12,034 Added 98.83%	24,211 $255,000
Q2 2022 Aug 03, 2022	BUY	$6.46 - $10.02 $78,663 - $122,013	12,177 New	12,177 $112,000
Q1 2022 May 02, 2022	SELL	$5.56 - $7.99 $58,913 - $84,662	-10,596 Closed	0 $0
Q4 2021 Feb 23, 2022	BUY	$5.26 - $8.3 $23,101 - $36,453	4,392 Added 70.79%	10,596 $85,000
Q2 2021 Aug 12, 2021	BUY	$3.11 - $4.61 $16,336 - $24,216	5,253 Added 552.37%	6,204 $19,000
Q1 2021 Apr 26, 2021	BUY	$3.03 - $4.58 $2,881 - $4,355	951 New	951 $0

128K

Ticker BLU
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 125,793,000
Description
BELLUS Health Inc., a clinical stage biopharmaceutical company, develops therapeutics for the treatment of refractory chronic cough (RCC) and other cough hypersensitivity indications. Its lead product candidate includes BLU-5937, an antagonist of the P2X3 receptor, which is in Phase II clinical trial for treatment of RCC and chronic pruritus. Th...

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Simplex Trading, LLC with notifications on news.